SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-22-042671
Filing Date
2022-02-15
Accepted
2022-02-14 21:55:07
Documents
2
Group Members
STEVEN BOYD

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d306468dsc13ga.htm SC 13G/A 62536
2 EXHIBIT A d306468dex99a.htm EX-99.A 2450
  Complete submission text file 0001193125-22-042671.txt   66595
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Subject) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88106 | Film No.: 22636868
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A